Trial Profile
A randomized, open study of either etanercept or tofacitinib in patients with severe rheumatoid arthritis (RA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2018
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Tofacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 18 Jul 2018 New trial record
- 16 Jun 2018 Results evaluating efficacy of Tofacitinib vs Etanercept in rheumatoid arthtritis patients (n=30) were presented at the 19th Annual Congress of the European League Against Rheumatism